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When discussing Surgical Oncology in Europe and when
we try to analyze the structures dealing with this specialty,
we first have to go back to history; we shall then see that
the surgical oncology work was and is organized quite
differently in the European countries; it will be clear that
the role of the surgical oncology societies is of great
importance.
Surgical oncology is not a static technical science;
we see topics and controversial themes change with the
time.
Definitions
But first definitions; what is surgical oncology? Should
not we start with oncological surgery?
Oncological surgery means specific technique and
approach to tumourous conditions. It is technique
adapted to and based upon our knowledge of tumour-
biology. The great steps forward were seen in the second
half of the 19th century.
Charles Hewitt Moore, surgeon of the Middlesex
Hospital in London made already in 1865 statements
which later were the background for the introduction of
radical operations, such as the Halsted radical mastec-
tomy. He was aware of the importance of taking out
tumors surrounded by a broad margin of healthy tissue to
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The paper gives a short history of surgical oncology in Europe, beginning with the 17th century and presents the present state
of this sophisticated field of medicine. The role of the different european medical societies and organizations devoted to surgical
oncology is also discussed, including the European Society of Surgical Oncology (ESSO), European School of Oncology
(ESO) and the European Organization for the Research and Treatment of Cancer (EORTC). The author completes the paper
by discussing the future possibilities of surgical oncology in Europe.
Chirurgia onkologiczna w Europie
W pracy zawarto krótki rys historyczny, ilustrujàcy rozwój chirurgii onkologicznej w Europie poczynajàc od XVII wieku
oraz przedstawiono obecny stan rozwoju tej z∏o˝onej dziedziny medycyny wspó∏czesnej. Obszernie omówiono rol´
poszczególnych europejskich towarzystw i organizacji naukowych w rozwoju chirurgii onkologicznej – European Society of
Surgical Oncology (ESSO), European School of Oncology (ESO) oraz European Organization for the Research and
Treatment of Cancer (EORTC). W podsumowaniu autor zawar∏ swoje spostrze˝enia dotyczàce dalszego rozwoju chirurgii
onkologicznej.
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Figure 1. Illustration in Armamentarium
Chirurgicum, posthumously published work by
Johann Scultetus (1595-1645)
avoid the risk of tumorseeding and to avoid local
recurrence because of non resected overlooked tumor-
extensions.
Alexander Hughes Bennett from Edinburgh mentio-
ned even years earlier how important the examination
of specimen margins is.
But already in the l7th century we find in books
that specific surgical instruments were developed for
tumorsurgery as is shown in one of the illustrations of the
famous surgical textbook of Scultetus, that only after his
death was published by his family, in 1679 (Figure 1).
From the same time is a report of a resection of
a parotid tumor. The documentation is perfect with
a detailed description of the tumor. On the engravings
from the report the result of the operation is proudly
shown (Figure 2). We should realize that it is a “short
term” result. We are before the era of refined oncological
surgery; I guess that the local recurrence risk is high in
this case.
Surgical oncology covers a much wider field than
oncological surgery: the role of the surgeon in the tumour
treatment. Apart from the surgical act the activities are
basic research, prevention and many other fields.
The roots of surgical oncology
We find the origin of this specialty in the cancer institutes,
initially founded as radium institutes in many countries in
the beginning of the previous century.
A most famous descendant of Poland played
a pivotal role in this process: Marie Sklodowska-Curie
discovered the radioactive power of radium, a few years
after Röntgen found the X-rays in 1895. The healing
effect of röntgenrays and of radioactivity was soon
detected and institutes, where such treatments could be
given, were built; the first in Buffalo, Moskou and
Heidelberg. Soon it was realized that also surgeons should
have important tasks in these cancer-centres;
So we might see Marie Sklodowska, who indeed
always underlined the multidisciplinary line, also as
mother of surgical oncology.
In Holland the Antoni van Leeuwenhoekhospital,
the Dutch national cancer institute started in 1913 in an
old canal mansion with 14 beds. In 1929 the move to an
old military building was needed because of the demand
for more beds. In 1979 the new hospital was built. Many
of the Polish oncologists know this building from visits.
Next year the new wing will make this institute still more
useful to treat the cancerpatients in an optimal way.
I mention this development of my institute because it is
exemplary for the enormous expansion of the cancer
centres in the last century. The surgical activities
contributed certainly to the increase in size.
Also the Polish cancer centre in Warszawa was built
as “Radium Institute”.
Now Poland has the biggest Cancer Institute in
Europe, for a great deal an achievement of the surgical
oncologist Andrzej Ku∏akowski.
Multidisciplinarity
Back to the surgical oncology. To be strong in the clinical
work the surgical oncologists need for the operation
planning optimal contacts with imaging groups and
pathologists.
Realizing that surgeons can as a rule not cover more
than the locoregional area (surgery for distant disease is
only exceptionally curative) the surgeons need to enlarge
the scope of their treatment effects by intensive coopera-
tion with medical oncologists; the radiotherapists help to
create a locoregional cure.
Fundamental research in oncology, also being
a major task, a continuous challenge for the surgical
oncologists, likewise means intensive contacts with other
specialties; multidisciplinarity is essential.
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Figure 2. Illustration (engraving) in an early 18th century Dutch "case history" of a parotid tumour
Teamwork and “volume”
With the increase of activities and the turbulent
developments of new techniques it was and is conti-
nuously necessary to enlarge the group of surgeons
working in oncology centres and subspecialization became
a logical development.
Teamwork, within these surgical groups, is important;
competition and hierarchy should be minimized and we
should be independent of economical constraints.
The increasing number of surgeons dealing with
a certain number of patients creates the discussion on
“volume”, the quantification of operations needed to
reach sufficient expertise to produce good work. Recent
publications suggest strongly that interest in oncology
and knowledge of tumorbiology-based techniques and
good organized follow-up, evaluating the results of the
work, are more important than volume; nevertheless
expertise needs a certain volume; many factors influence
the actual size of such volume.
New techniques and conceptual changes
Over the years our armamentarium is enlarged and many
new fields of activities were added, underlining the
intensity and wide range of activities by surgical
oncologists. The list is long: Microsurgery enabled the
performing of free flaps, needed for difficult reconstruc-
tions. Endoscopic experience now culminates in minimal
invasive surgery, with possible usefulness in oncology.
Not only regional chemotherapy (perfusions and infu-
sions), also the neoadjuvant approach and peroperative
radiotherapy, all with specific technical aspects, are fields
of research for surgical oncologists. Radioguided surgery
is helpful e.g. in optimizing the regional surgery.
We have seen a change of many concepts: Work of
surgical oncologists, tested in good clinical research made
that the superradical approach is replaced by non
mutilating surgery. The need of wide surgical exposure
now is challenged by the supporters of the minimal
invasive approach and we all are aware that the treatment
of the regional nodes now is quite different from that in
the 70’s and 80’s.
The place of surgical oncology within the frame of
general surgery
Surgical oncology is an important subdivision of surgery.
There is, however, a major concern when we discuss the
place of our field within the organization of surgery.
Surgical oncology is disease based, whereas most other
surgical organizations are organ based. This is also one of
the explanations of the fact that in many countries surgical
oncology not yet is recognized as a specialty.
Surgical oncology was born in the cancer centres;
continued fostering from such institutes is essential for
further developments. In a number of general surgery
departments flourishing surgical oncology subgroups
vanished away with a change of the boss, when the head
of the department was followed by someone with interests
other than oncology. We have recently seen such lack of
continuity in Groningen and in Edinbourgh. Such a loss
will never be seen in cancer centres.
The twofold roots: surgery and oncology have
complicated and organizationally hybrid consequences. 
National organizations
The national organizations are differently organized: An
independent society, or as subgoup of either the surgical
society or oncology society. In some countries the surgical
oncologists prefer to function as a group under the
umbrella of the European Society of Surgical Oncology.
The first of such national organizations was the
James Ewing Society (later named the SSO), in the USA.
In Europe, in the United Kingdom, Ronald Raven and
Ian Burn founded already in 1971 the British Association
of Surgical Oncology (BASO). In 1976 Italy followed.
Most countries, including Poland and The Netherlands,
had their surgical oncology organization founded not
before the 90’s.
The task of the National Societies is manyfold. The
formation of studygroups for clinical research is im-
portant. Participation in large clinical trials is stimulated.
Meetings are used to diffuse progress; education and
quality control is given great attention.
European cooperation
How can we work together in Europe? The link can be
organized by the societies, by the cancer centres or by
trial organizations and researchgroups. Four European
organizations are important for us: The European Society
of Surgical Oncology (ESSO), our Journal, the European
Journal of Surgical Oncology (EJSO), the European
School of Oncology (ESO) and the European
Organization for the Research and Treatment of Cancer
(EORTC), with its most important goal the running of
clinical trials.
Already in the twenties cancer centres organized
international meetings to exchange information. One of
the first of such meetings was organized in Amsterdam
(Figure 3). Surgical themes were prominent on the
agenda. It is curious to know that during that conference
an International Leeuwenhoek Society was founded.
Some years later this group changed name and became
the UICC, the Union Internationale Contre le Cancer,
still the most important oncology organization in the
world.
The European Society of Surgical Oncology (ESSO)
In the beginning of the 80’s it was felt that European
cooperation was essential to reinforce surgical oncology in
this continent. Umberto Veronesi, famous surgeon and
pathologist from Milano took the initiative to found the
ESSO. Since long he dominates the European spirit
among the surgical oncologists. From this background
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he founded also the European Institute of Oncology in
Milano, now competative with the famous Istituto di
Tumori, which he headed so many years. Also the
European School of Oncology is one of his children.
In the list of the ESSO founders figure representa-
tives of almost all European countries.
ESSO is an active member of the Federation of
European Cancer Societies (FECS) and of the World
Federation of Surgical Oncology Societies (WFSOS)
illustrating that contact with other oncology-specialties
and with colleagues from outside Europe is onsidered to
be highly important.
The main goal from our European Society is to
promote and improve the surgical part of tumour-
treatment: Education through meetings, fellowships,
awards and, most important, through the European
Journal of Surgical Oncology (EJSO).
Figure 4 shows a recent meeting of the Executive of
ESSO, with Bin Kroon in the chair and, among others,
the respresentative of Poland Janusz Jaskiewicz, the
editor-in-chief of our journal Irving Taylor and to the
right the actual president-elect Luigi Cataliotti.
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Figure 3. International Cancer Conference, 1922, in Amsterdam; Fibiger (Copenhagen) and Leitch (London), both famous pathologists, 
were among the participants
Figure 4. A recent meeting of the ESSO executive committee. From left to right Irving Taylor,
editor-in-chief of the EJSO, Janusz JaÊkiewicz and Schlomo Schneebaum, councillors, Bin Kroon,
the now past-president and Luigi Cataliotti, president-elect
The European Organization for the Research and
Treatment of Cancer (EORTC)
The EORTC is the other European organization in
which surgical oncologists are active. Founded as GECA,
Groupe Européen de Chimiotherapie Anticancereuse, it
soon became multidisciplinary. Also Polish Institutes
participate actively in the EORTC activities.
The founder, Henri Tagnon (Figure 5), a medical
oncologist, was working for the idea of the European
Union “avant la lettre”. He was a great visionary of even
global cooperation in oncology. He created the European
Data Centre in Brussels, but in the same time he
organized close links with the National Cancer Institute of
the United States. Being the founder and first editor of
the European Journal of Cancer, one of the oncology
journals with already soon a high impact factor, he
stimulated to report on all new findings of the studies in
an own European, multidisciplinary cancer journal. Also
the surgeons are indebted to him for all these
achievements.
The main task of the EORTC is to perform
prospective randomized trials.
Also in our surgical part of tumour treatment we
need this type of investigations to give our therapy choices
a solid background and to answer the many still open
questions. The work in the studygroups of the EORTC is
highly stimulating and everybody who sofar had no
contacts is invited to join one of these cooperative groups.
Problems in the European cooperation
An open eye for the problems in european cooperation is
needed.
A main point is the lack of internationally, generally
accepted definitions in still many fields. We need manuals,
like the manual published by the Breast Cancer
Cooperative of the EORTC group. This relates to
diagnostics, to treatment-principles, to operation types,
and also to ethical principles.
Many still existing differences in the interpretation of
words and treatment principles between countries make
that the creation of European treatment protocols often
is difficult; here the text of a protocol can be hazy in some
aspects (with incidentally impact on the strength of the
outcome). So we have to work strong on the uniformity of
interpretations.
Future
The Cancer Institutes should keep their active role in
leading the surgical oncology. Surgical oncology in the
universities and regional hospitals needs a solid organiza-
tion; The “comprehensive cancer centre” structure is the
most productive form and is a safeguard for continuity.
We have to work together, internationally, within the
ESSO and the EORTC; these organizations need the
support of all. Within these groups and within the national
societies manuals and guidelines should be worked out,
improving the quality of the work; the educational task is
of great importance and should be part of the work of
all surgical oncologists.
We all have to submit our most important publi-
cations to the EJSO, our own surgical oncology journal;
the constantly rising impact factor is an extra stimulus!
Conferences should be organized, like now by the Polish
surgical oncology society, with a focus on a specific theme,
which then can be explored in depth.
For all this work, now and in the future, one is
recompensed by making friendship with many colleagues,
just as has been the experience of the author, who is
happy to meet again his many Polish friends.
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Figure 5. Henri Tagnon (1911-2000), founder of
the EORTC and founder-editor of the European
Journal of Cancer
